Fever is a common symptom in clinical practice, often indicating an underlying pathological condition. Despite its ubiquity, approaching fever diagnostically can be complex due to its myriad of potential causes. This guide aims to elucidate the diagnostic approach to fever in clinical practice.
The first step in diagnosing fever involves a comprehensive patient history and physical examination. Key information includes the onset, duration, and pattern of fever, associated symptoms, recent travel, and medical history. Physical examination should focus on identifying signs of infection or inflammation and potential sources of fever.
Lab investigations play a critical role in the diagnostic process. The choice of tests should be guided by the clinical suspicion. Basic investigations often include complete blood count, CRP, blood cultures, urinalysis, and chest X-ray. More specific tests, such as serology or PCR for suspected infectious diseases, may be warranted based on the clinical picture.
When initial investigations do not yield a diagnosis, imaging and specialized tests may be necessary. CT, MRI, or ultrasound can identify localized sources of infection or inflammation. Specialized tests, like lumbar puncture or biopsy, may be needed for suspected central nervous system infections or malignancies respectively.
Management of fever is typically symptomatic, with the aim of alleviating discomfort and preventing complications. Definitive treatment depends on the underlying cause. Regular follow-up is crucial to monitor response to treatment and adjust the management plan as necessary.
Diagnosing fever requires a systematic approach, combining clinical assessment, laboratory investigations, and potentially imaging or specialized tests. Understanding this process is essential for healthcare professionals to ensure effective patient management and optimal outcomes.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation